相似文献
1
Unanswered questions and future direction in the management of terminal breathlessness in patients with cancer.
ESMO Open. 2020;5 Suppl 1(Suppl 1):e000603. doi: 10.1136/esmoopen-2019-000603. Epub 2020 Sep 30.
2
The etiology and management of intractable breathlessness in patients with advanced cancer: a systematic review of pharmacological therapy.
Nat Clin Pract Oncol. 2008 Feb;5(2):90-100. doi: 10.1038/ncponc1034.
3
Breathlessness in cancer patients - implications, management and challenges.
Eur J Oncol Nurs. 2011 Dec;15(5):459-69. doi: 10.1016/j.ejon.2010.11.013. Epub 2011 Jan 15.
4
Management of refractory breathlessness in patients with advanced cancer.
Wien Med Wochenschr. 2009 Dec;159(23-24):591-8. doi: 10.1007/s10354-009-0728-y.
5
Development of a breathlessness assessment guide for use in palliative care.
Palliat Med. 1999 Sep;13(5):375-84. doi: 10.1191/026921699674958656.
6
Nonpharmacological Interventions for Managing Breathlessness in Patients With Advanced Cancer: A Systematic Review.
JAMA Oncol. 2021 Feb 1;7(2):290-298. doi: 10.1001/jamaoncol.2020.5184.
7
The clinical and cost effectiveness of a Breathlessness Intervention Service for patients with advanced non-malignant disease and their informal carers: mixed findings of a mixed method randomised controlled trial.
Trials. 2016 Apr 4;17:185. doi: 10.1186/s13063-016-1304-6.
8
Who experiences higher and increasing breathlessness in advanced cancer? The longitudinal EPCCS Study.
Support Care Cancer. 2016 Sep;24(9):3803-11. doi: 10.1007/s00520-016-3207-1. Epub 2016 Apr 9.
9
Pharmacologic Interventions for Breathlessness in Patients With Advanced Cancer: A Systematic Review and Meta-analysis.
JAMA Netw Open. 2021 Feb 1;4(2):e2037632. doi: 10.1001/jamanetworkopen.2020.37632.
10
Do the trajectories of dyspnea differ in prevalence and intensity by diagnosis at the end of life? A consecutive cohort study.
J Pain Symptom Manage. 2010 Apr;39(4):680-90. doi: 10.1016/j.jpainsymman.2009.09.017.
引用本文的文献
1
Dyspnoea in intensive care unit: a truly multi-professional problem.
Intensive Care Med. 2024 Jul;50(7):1190-1191. doi: 10.1007/s00134-024-07455-y. Epub 2024 May 6.
2
Trends in pain undertreatment among lung cancer patients at the EOL: Analysis of urban city medical insurance data in China.
Thorac Cancer. 2024 Mar;15(9):693-701. doi: 10.1111/1759-7714.15240. Epub 2024 Feb 5.
3
Improved Symptom Change Enhances Quality of Dying in Patients With Advanced Cancer: An East Asian Cross-Cultural Study.
Oncologist. 2024 Apr 4;29(4):e553-e560. doi: 10.1093/oncolo/oyad269.
4
Current Management Options for Dyspnea in Cancer Patients.
Curr Treat Options Oncol. 2023 Jun;24(6):565-579. doi: 10.1007/s11864-023-01081-4. Epub 2023 Apr 11.
5
Dyspnea in Oncological Patients: a Brain Teaser.
Eur Cardiol. 2023 Feb 3;18:e03. doi: 10.15420/ecr.2021.62. eCollection 2023 Feb.
6
The feasibility and effects of a pharmacological treatment algorithm for cancer patients with terminal dyspnea: A multicenter cohort study.
Cancer Med. 2023 Mar;12(5):5397-5408. doi: 10.1002/cam4.5362. Epub 2022 Oct 19.
7
Management of Physical Symptoms in Patients with Advanced Cancer during the Last Weeks and Days of Life.
Cancer Res Treat. 2022 Jul;54(3):661-670. doi: 10.4143/crt.2022.143. Epub 2022 Jun 30.
8
Prognostication of the Last Days of Life.
Cancer Res Treat. 2022 Jul;54(3):631-643. doi: 10.4143/crt.2021.1573. Epub 2022 Mar 30.
9
The Bereaved Families' Preferences for Individualized Goals of Care for Terminal Dyspnea: What Is an Acceptable Balance between Dyspnea Intensity and Communication Capacity?
Palliat Med Rep. 2020 May 14;1(1):42-49. doi: 10.1089/pmr.2020.0035. eCollection 2020.
本文引用的文献
1
Immediate Effect of Fan Therapy in Terminal Cancer With Dyspnea at Rest: A Meta-Analysis.
Am J Hosp Palliat Care. 2020 Apr;37(4):294-299. doi: 10.1177/1049909119873626. Epub 2019 Sep 4.
2
How successful are we in relieving terminal dyspnea in cancer patients? A real-world multicenter prospective observational study.
Support Care Cancer. 2020 Jul;28(7):3051-3060. doi: 10.1007/s00520-019-05081-9. Epub 2019 Oct 19.
3
Oral modified release morphine for breathlessness in chronic heart failure: a randomized placebo-controlled trial.
ESC Heart Fail. 2019 Dec;6(6):1149-1160. doi: 10.1002/ehf2.12498. Epub 2019 Aug 6.
4
The Current Practice of Oxygen Therapy for Dyspnea in Terminally Ill Cancer Patients: A Nationwide Survey of Japanese Palliative Care Physicians.
J Pain Symptom Manage. 2019 Oct;58(4):e2-e4. doi: 10.1016/j.jpainsymman.2019.06.028. Epub 2019 Jul 5.
5
Strategies for Pain Assessment in Adult Patients With Delirium: A Scoping Review.
J Pain Symptom Manage. 2019 Sep;58(3):487-502.e11. doi: 10.1016/j.jpainsymman.2019.05.020. Epub 2019 Jun 10.
6
Fan Therapy for the Treatment of Dyspnea in Adults: A Systematic Review.
J Pain Symptom Manage. 2019 Sep;58(3):481-486. doi: 10.1016/j.jpainsymman.2019.04.011. Epub 2019 Apr 18.
7
Palliative Care Physicians' Practice in the Titration of Parenteral Opioids for Dyspnea in Terminally Ill Cancer Patients: A Nationwide Survey.
J Pain Symptom Manage. 2019 Jul;58(1):e2-e5. doi: 10.1016/j.jpainsymman.2019.04.007. Epub 2019 Apr 15.
8
Symptom correlates of dyspnea in advanced cancer patients using the Edmonton Symptom Assessment System.
Support Care Cancer. 2020 Jan;28(1):87-98. doi: 10.1007/s00520-019-04787-0. Epub 2019 Apr 13.
9
Systemic corticosteroids for the management of cancer-related breathlessness (dyspnoea) in adults.
Cochrane Database Syst Rev. 2019 Feb 20;2(2):CD012704. doi: 10.1002/14651858.CD012704.pub2.
10
Reflections on palliative sedation.
Palliat Care. 2019 Jan 27;12:1178224218823511. doi: 10.1177/1178224218823511. eCollection 2019.
Zotero 插件